Trials / Completed
CompletedNCT06401473
Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections
Closing the Gate: Investigating a No-Cost, Noninvasive, Patient-Driven Approach to Pain Reduction for Trigger Finger Injections
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Grand Canyon University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to investigate a new noninvasive technique that patients may use to help reduce the pain that they experience during cortisone injections for trigger fingers. It will also help provide information that may help support the gate control theory of pain as a framework for understanding and managing acute pain.The main questions it aims to answer are: Can a physical stimulus near the site of cortisone injection reduce the pain experienced by the patient during the injection? Does the physical stimulation or the cognitive distraction contribute more to pain relief? Researchers will compare a physical stimulus near the injection site to a placebo (a similar task that theoretically should not reduce the experience of pain) to see if physical stimuli work to improve pain during injections. Participants will: Estimate how much pain they expect to experience during a cortisone injection Receive a cortisone injection for a trigger finger while performing one of three possible actions (control, placebo task, or the investigated physical stimulus near the injection site) Express how much pain they actually experienced during the injection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Ipsilateral Scratch Task | Patients scratch the skin within the relevant cervical dermatome, ipsilateral to the injection site |
| BEHAVIORAL | Motor Distraction Task | Patients scratch the skin of the shoulder/neck contralateral to the injection site |
Timeline
- Start date
- 2023-09-11
- Primary completion
- 2024-04-11
- Completion
- 2024-04-11
- First posted
- 2024-05-06
- Last updated
- 2024-05-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06401473. Inclusion in this directory is not an endorsement.